Protara Therapeutics, Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.86M2.95M
Gross Profit -0.86M2.95M
Operating items
Research & Development 3.99M6.43M
Selling, General & Administrative 3.13M4.10M
Operating Expenses 7.12M10.53M
Operating Income -7.12M-7.58M
EBIT -7.12M-7.58M
Non-operating items
Interest & Investment Income 0.00M-0.86M
Other Non Operating Income 0.07M5.07M
Non Operating Income -0.79M5.07M
Net income details
EBT -7.98M-9.29M
Profit After Tax -7.91M-3.34M
Income from Continuing Operations -7.98M-9.29M
Consolidated Net Income -7.98M-9.29M
Income towards Parent Company -7.98M-9.29M
Preferred Dividend Payments 6.12M6.35M
Net Income towards Common Stockholders -14.03M-9.70M
Additional items
EPS (Basic) -0.00M-0.00M
Shares Outstanding (Weighted Average) 0.41M0.41M0.41M0.44M0.48M0.49M11.21M11.24M11.27M11.36M20.63M
EBITDA -7.12M-3.35M